Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas.

Gielen GH, Gessi M, Hammes J, Kramm CM, Waha A, Pietsch T.

Am J Clin Pathol. 2013 Mar;139(3):345-9. doi: 10.1309/AJCPABOHBC33FVMO.

PMID:
23429371
2.

Chromatin remodeling defects in pediatric and young adult glioblastoma: a tale of a variant histone 3 tail.

Fontebasso AM, Liu XY, Sturm D, Jabado N.

Brain Pathol. 2013 Mar;23(2):210-6. doi: 10.1111/bpa.12023. Review.

PMID:
23432647
3.

Genetic profile of astrocytic and oligodendroglial gliomas.

Ohgaki H, Kleihues P.

Brain Tumor Pathol. 2011 Jul;28(3):177-83. doi: 10.1007/s10014-011-0029-1. Epub 2011 Mar 26. Review.

PMID:
21442241
4.

Histone H3 mutations--a special role for H3.3 in tumorigenesis?

Kallappagoudar S, Yadav RK, Lowe BR, Partridge JF.

Chromosoma. 2015 Jun;124(2):177-89. doi: 10.1007/s00412-015-0510-4. Epub 2015 Mar 14. Review.

5.

Mutations in chromatin machinery and pediatric high-grade glioma.

Lulla RR, Saratsis AM, Hashizume R.

Sci Adv. 2016 Mar 18;2(3):e1501354. doi: 10.1126/sciadv.1501354. eCollection 2016 Mar. Review.

6.

Molecular biomarkers in pediatric glial tumors: a needed wind of change.

Fontebasso AM, Bechet D, Jabado N.

Curr Opin Oncol. 2013 Nov;25(6):665-73. doi: 10.1097/CCO.0000000000000007. Review.

PMID:
24097106
7.

The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children.

Lee J, Solomon DA, Tihan T.

J Neurooncol. 2017 Mar;132(1):1-11. doi: 10.1007/s11060-016-2349-9. Epub 2017 Jan 7. Review. Erratum in: J Neurooncol. 2017 Mar;132(1):13.

PMID:
28064387
8.

Pathological and molecular advances in pediatric low-grade astrocytoma.

Rodriguez FJ, Lim KS, Bowers D, Eberhart CG.

Annu Rev Pathol. 2013 Jan 24;8:361-79. doi: 10.1146/annurev-pathol-020712-164009. Epub 2012 Oct 29. Review.

9.

Histone H3 mutations in pediatric brain tumors.

Liu X, McEachron TA, Schwartzentruber J, Wu G.

Cold Spring Harb Perspect Biol. 2014 Apr 1;6(4):a018689. doi: 10.1101/cshperspect.a018689. Review.

10.

Pediatric high-grade astrocytomas: a distinct neuro-oncological paradigm.

Gerges N, Fontebasso AM, Albrecht S, Faury D, Jabado N.

Genome Med. 2013 Jul 30;5(7):66. doi: 10.1186/gm470. eCollection 2013. Review.

11.

Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas.

Vanan MI, Underhill DA, Eisenstat DD.

Neurotherapeutics. 2017 Apr;14(2):274-283. doi: 10.1007/s13311-017-0514-2. Review.

PMID:
28233220
12.

The molecular biology of WHO grade I astrocytomas.

Marko NF, Weil RJ.

Neuro Oncol. 2012 Dec;14(12):1424-31. doi: 10.1093/neuonc/nos257. Epub 2012 Oct 22. Review.

13.

The molecular landscape of pediatric brain tumors in the next-generation sequencing era.

Firme MR, Marra MA.

Curr Neurol Neurosci Rep. 2014 Sep;14(9):474. doi: 10.1007/s11910-014-0474-4. Review.

PMID:
25037717
14.

Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma.

Williams MJ, Singleton WG, Lowis SP, Malik K, Kurian KM.

Front Oncol. 2017 Mar 28;7:45. doi: 10.3389/fonc.2017.00045. eCollection 2017. Review.

15.

Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine Glioma.

Buczkowicz P, Hawkins C.

Front Oncol. 2015 Jun 30;5:147. doi: 10.3389/fonc.2015.00147. eCollection 2015. Review.

16.

Molecular markers in pediatric neuro-oncology.

Ichimura K, Nishikawa R, Matsutani M.

Neuro Oncol. 2012 Sep;14 Suppl 4:iv90-9. doi: 10.1093/neuonc/nos204. Review.

17.

Pediatric brain tumors.

Brandão LA, Poussaint TY.

Neuroimaging Clin N Am. 2013 Aug;23(3):499-525. doi: 10.1016/j.nic.2013.03.003. Epub 2013 May 18. Review.

PMID:
23928202
19.

The future of neuropathology in childhood.

Rorke LB.

Childs Nerv Syst. 2000 Nov;16(10-11):805-8. Review.

PMID:
11151734

Supplemental Content

Support Center